Find Academic Supervisors

Find and connect with academic supervisors, professors, and scholars for your research journey.

Showing 31-45 of 4,985 supervisors

Profile data may be stale. It is sourced from public faculty pages.

Patrick M. GillevetView profile

Professor

George Mason UniversityUnited States

Patrick M. Gillevet is a Professor and Director of the Microbiome Analysis Center at George Mason University, with a primary appointment in the Biology Department and affiliate faculty status in the School of Systems Biology. His career focuses on integrating genomics, bioinformatics, and molecular ecology to study microbiome interactions in human health and environmental systems, including the development of multitag sequencing for high-throughput microbial analysis. Education: Ph.D., Biochemistry, University of Manitoba (1982) B.S., Microbiology, University of Toronto (1976) His research explores dysbiosis in the human microbiome (gut, mouth, urogenital, respiratory tracts) and its role in diseases, cognitive function, and social behavior. He pioneered the concept of the "metabiome" to describe host-microbiome interactions in systems biology. Key projects include analyzing multitag sequencing for evolutionary studies and microbial community characterization in ecosystems. Recent publications highlight collaborations on gut microbiome trends in cirrhosis, alcohol use disorder, and antibiotic resistance, with a focus on cross-sectional and longitudinal analyses. His work spans clinical trials (e.g., griffithsin gel), dietary interventions, and environmental microbiome studies.

Official University Profile

Antti PosoView profile

Professor

University of Eastern FinlandFinland

Antti Poso is a Professor of Drug Design at the University of Eastern Finland (Kuopio), affiliated with the School of Pharmacy under the Faculty of Health Sciences. His research focuses on computer-aided molecular design, particularly targeting anti-cancer drugs and anti-microbials. Key projects include the EDCMET project (2019–2024) and the GeneCellNano Flagship (2020–2028). He leads the Molecular Modeling and Drug Design Research Group, specializing in QSAR analysis, kinase inhibition profiling, and systems-level drug response modeling. Recent work includes studies on SARS-CoV-2 inhibitors, endocrine disruptors, and bacterial pathogenesis. His findings bridge chemical structure with biological outcomes, leveraging computational tools like CCA and molecular dynamics simulations. Collaborations span medicinal chemistry, pharmacology, and systems biology, contributing to both academic and applied drug discovery efforts. Education: Not explicitly stated in texts; assumed to hold advanced degrees in pharmacy or chemistry. Research Themes: Drug design, molecular modeling, QSAR, computational biology, and anti-infective agents. Key Contributions: Over 150+ publications, including influential works on chemoinformatics-driven drug response analysis and structure-based inhibitor design. Publications highlight advancements in kinase inhibitors, anti-microbial strategies, and viral hijacking mechanisms. His work emphasizes translating computational insights into therapeutic solutions for cancer, infectious diseases, and metabolic disorders.

Official University Profile

Curtis SuttleView profile

Professor

University of British ColumbiaCanada

Curtis Suttle is a Professor in the Department of Botany at the University of British Columbia's Faculty of Science. He also holds affiliations with Earth and Ocean Sciences, Microbiology and Immunology, and the Institute for Oceans and Fisheries. His research focuses on marine virology and the ecological roles of viruses in aquatic ecosystems, particularly their impact on phytoplankton and microbial communities. Dr. Suttle received his B.Sc. and Ph.D. from UBC, was a Coastal Marine Scholar at SUNY StonyBrook (1987-88), and served as Assistant/Associate Professor at the University of Texas at Austin (1988-96) before returning to UBC. His research program investigates the biology and ecology of viruses that infect microalgae and cyanobacteria. Key areas include discerning viral effects on primary productivity, isolating novel marine viruses, developing molecular identification methods, and studying viral distribution patterns. His work has revealed that viruses can occur in seawater at concentrations exceeding 10 5 ml -1 , with cyanophage concentrations reaching 10 6 infectious units ml -1 in coastal waters. Dr. Suttle's team has developed PCR primers specific for viral DNA polymerase genes, showing these viruses belong to a single family related to herpes viruses. Recent publications show a strong focus on marine viral ecology, with particular attention to oyster microbiomes, viral taxonomy, and the role of viruses in marine ecosystems. His research spans from coastal environments to the deepest ocean trenches, examining viral diversity across environmental gradients and investigating viral impacts on carbon cycling and marine food webs. Dr. Suttle leads an active research group with several post-doctoral associates, research scientists, and graduate students. His team conducts field work at multiple locations including the Naica Mine in Mexico, Pavilion Lake in British Columbia, Saanich Inlet, and the Strait of Georgia. Current projects include collaborations with the Hakai Institute, Line P Research Cruise, and CASES (Canadian Arctic Shelf Exchange Study). His laboratory has made significant contributions to understanding viral roles in marine ecosystems, particularly through expeditions to extreme environments like the Naica crystal caves and deep ocean trenches. Ongoing research explores viral impacts on microbial community structure, carbon cycling, and ecosystem function across diverse marine habitats.

Official University Profile

Betsy FoxmanView profile

Professor

University of Michigan-Ann ArborUnited States

Betsy Foxman serves as the Hunein F. and Hilda Maassab Professor of Epidemiology at the University of Michigan School of Public Health. She directs three major initiatives: the Center for Molecular and Clinical Epidemiology of Infectious Diseases, the Integrated Training in Microbial Systems program, and the Certificate in Healthcare Infection Prevention & Control. Her academic leadership spans decades with continuous research contributions. Dr. Foxman earned her PhD and MSPH from UCLA (1983, 1980) and BS from UC Berkeley (1977). Her research centers on infectious disease transmission, microbiome ecology, antibiotic resistance, and wastewater surveillance . Key projects include analyzing the oral microbiome in dental caries using genomic methods, studying nose/throat microbiome associations with respiratory infections in nursing facilities, and developing wastewater monitoring for antibiotic-resistant pathogens. Her work integrates next-generation sequencing with epidemiological analysis to identify novel interventions. Publication trends reveal consistent focus on microbiome-pathogen interactions across multiple body sites (oral, vaginal, gut, respiratory). Recent articles demonstrate methodological innovation in wastewater epidemiology (2024 Norovirus GII monitoring) and clinical applications like predicting vancomycin-resistant enterococci contamination (2023 Lancet study). Her research bridges molecular microbiology with population health, emphasizing translational potential for diagnostics and public health interventions. Fellow of the Infectious Disease Society of America Fellow of the American College of Epidemiology Fellow of the American Academy of Microbiology Dr. Foxman's advising portfolio includes numerous NIH-funded projects on microbiome dynamics and infection control. Her leadership in the Center for Molecular and Clinical Epidemiology drives collaborative research across departments. Current initiatives focus on wastewater surveillance standardization and microbiome-based diagnostics for infection prevention. She maintains active laboratories for genomic analysis of microbial communities and clinical sample processing.

Official University Profile

Hans SteenackersView profile

Associate Professor

KU LeuvenBelgium

Hans Steenackers is an Associate Professor at the Faculty of Bioscience Engineering, KU Leuven, where he leads the MICA Lab within the Department of Microbial and Molecular Systems. His research focuses on innovative antimicrobial strategies targeting microbial communities, including socio-active, anti-resistance, and observation-guided approaches. Key research areas include biofilm dynamics antimicrobial resistance evolution in situ microbial monitoring Salmonella Typhimurium pathogenesis anti-virulence therapies His recent publications highlight advancements in biofilm inhibition, triggered antimicrobial release systems, and evolutionary robustness of probiotics. The majority of his work involves interdisciplinary collaborations, particularly in projects like TARDIS, ULTiMatE-MS, and MICROTUNe, with a focus on translating fundamental research into clinical applications. As an educator, he teaches advanced courses in microbial physiology, biofilm research, and applied biotechnology. The MICA Lab actively partners with academic and industrial stakeholders in initiatives such as the Flemish Scientific Research Network on Biofilms and the Bioclean H2020 project.

Official University Profile

Owen SkinnerView profile

Assistant Professor

Northeastern UniversityUnited States

Owen Skinner is an Assistant Professor in the Department of Chemistry and Chemical Biology at Northeastern University, affiliated with the Barnett Institute of Chemical and Biological Analysis. He leads the Skinner Lab, which specializes in high-resolution mass spectrometry to study protein-metabolite interactions in health and disease. Skinner earned his Ph.D. from Northwestern University and conducted postdoctoral research at Massachusetts General Hospital. His research focuses on thiol redox regulation, vitamin cofactor metabolism, and oxidative phosphorylation dynamics. Education: Ph.D. in Chemistry (Northwestern University), Postdoctoral Fellowship in Analytical Chemistry (Massachusetts General Hospital). Research interests include proteomics, metabolomics, mitochondrial dysfunction, and metabolic signaling. The lab actively recruits graduate students, undergraduates, and postdoctoral researchers across Northeastern's scientific community. Affiliations: Barnett Institute, College of Science Lab Members: PhD students Yifan Liu, Michael Xiao, Angela Rojas-Merchan; Undergraduates Helena Rittenhouse, Ridha Shah; High School collaborator Helen Loango Techniques: Native mass spectrometry, proteomics, metabolomics, redox biology Publications span mitochondrial metabolism, metabolic biomarkers in septic shock, and enzyme engineering. The lab emphasizes interdisciplinary collaboration and supports students through Northeastern's experiential learning programs.

Official University Profile

Jean Van Den ElsenView profile

Professor

University of BathUnited Kingdom

Prof Jean Van Den Elsen is a Professor of Biochemistry at the University of Bath , affiliated with the Department of Life Sciences and several research centers including the Centre for Sustainable Chemical Technologies (CSCT) , Centre for Therapeutic Innovation , and Milner Centre for Evolution . They are actively accepting doctoral students and leading multidisciplinary projects at the intersection of structural biology and immunology. Education: Not explicitly mentioned Appointments: University of Bath (current), with collaborations across Chemistry, Biology & Biochemistry departments Research Focus: The laboratory investigates protein structural biology in two major areas: Complement System Interactions: Studying how pathogenic microbes like Staphylococcus aureus evade host immunity through complement system manipulation , with structural analysis of proteins such as C3d and C5 complexes. This work directly informs vaccine design and autoimmune disease treatment . Glycation Mechanisms: Developing diagnostic tools for detecting non-enzymatic sugar modifications linked to diabetes , Alzheimer's , and aging, with commercial partnerships like Abcam . Article Trends: Recent publications demonstrate: Structural analysis of complement evasion proteins (2022-2025) Engineering knob domains as miniature antibodies (2023) Evolutionary studies on cooperative behavior (2021-2025) Advancements in peptide synthesis platforms (2022-2023) Applications of AI protein folding (2020) Scientific Contributions: ORCID: 0000-0002-0367-1956 BBSRC Funding recipient (2023) 100+ citations across 76 research outputs Student Mentorship: Directly supervising 4 current PhD students and 1 postdoc, with a track record of mentoring 11 previous students including Daphne Jackson Fellows and MSCA researchers. Collaborations: Maintains active partnerships with Dr. Tony James (Chemistry), Dr. Rob Williams (Biochemistry), and industry partners UCB Celltech and Porton Biopharma Ltd. Their work contributes to UN Sustainable Development Goals 3 (Good Health), 12 (Responsible Consumption), and 13 (Climate Action).

Official University Profile

Tariq ButtView profile

Professor

Swansea UniversityUnited Kingdom

Professor Tariq Butt of Swansea University's Faculty of Science and Engineering leads the Biocontrol and Natural Products (BANP) group , focusing on entomopathogenic fungi and natural product-based biopesticides for managing pests impacting food security , human health , and agriculture . He co-directs the Natural Products BioHub and Health Technology Solutions Research Institute . His cross-disciplinary research includes collaborations with Dr Joel Loveridge (Chemistry) for chemical ecology, Professor Chedly Tizoui (Engineering) for plant-based molluscicides, and Professor Dan Eastwood (Biosciences) for fungal biocontrol. Externally, he works with experts in Greece, Brazil, Turkey, Saudi Arabia , and companies like Certis Belchim and Lallemand . Recent publications highlight his work on fungal volatile organic compounds for pest control, mosquito repellents , and microbial consortia to reduce chemical dependencies. He has supervised over 35 PhD/MSc students and contributed to 174+ peer-reviewed articles and 14 book chapters .

Official University Profile

Anne Berit C. SamuelsenView profile

Associate Professor

University of OsloNorway

Anne Berit C. Samuelsen serves as Associate Professor at the Department of Pharmacy, University of Oslo, where she also holds the position of Head of Education. Her academic foundation includes a Cand.pharm. degree and Dr.scient. doctorate, establishing her expertise in pharmaceutical sciences. Her research centers on polysaccharides from natural sources—particularly higher plants, cereals, and fungi (Basidiomycota)—with specialized focus on β-glucans. Key interests include carbohydrate chemistry, pharmacognosy, and the development of biopolymer-based pharmaceutical applications. Her work bridges fundamental structural characterization with practical drug delivery solutions, notably through liposome coating technologies and immunomodulatory compound development. Recent publications reveal a strong trajectory in fungal polysaccharide research, particularly with Pleurotus eryngii and Albatrellus ovinus species. Her team employs advanced techniques like diffusion-ordered NMR spectroscopy to analyze polysaccharide structures while investigating biological activities related to immune receptor binding (Dectin-1, Toll-like receptors) and therapeutic applications. This work demonstrates consistent output in high-impact journals including Carbohydrate Polymers and ACS Applied Bio Materials . She actively contributes to academic instruction through courses such as FARM1150 (Pharmaceutically Oriented Biochemistry), FARM3100 (Pharmacognosy), and FARM5200 (Use of Biopolymers in Pharmaceuticals). Her leadership extends to the Bioactive Natural Substances and Health Effects (BioNatH) research group and the Glyconor Consortium, where she investigates natural product applications for health improvement.

Official University Profile

Sebastian HillerView profile

Professor

University of BaselSwitzerland

Professor Sebastian Hiller is a Full Professor at the Biozentrum of the University of Basel, Switzerland, where he leads a research group focused on structural biology and biophysics. His laboratory specializes in using nuclear magnetic resonance (NMR) spectroscopy to elucidate the structures and functions of proteins and their interactions at the atomic level. His research spans several key areas including molecular chaperones and protein folding mechanisms, outer membrane protein biogenesis in bacteria, and kinase signaling pathways. Notably, his group has made significant contributions to understanding how chaperones like trigger factor function, the mechanisms of outer membrane protein assembly through the Bam complex, and dynamic kinase interactions. Their work has direct implications for neurodegenerative diseases and antibiotic development. The Hiller lab's recent publications demonstrate a strong focus on NMR methodology development, protein folding dynamics, and structural mechanisms of antibiotic action. Their research on darobactin's mechanism of action against Gram-negative bacteria represents a significant advance in antibiotic discovery. The group frequently publishes in high-impact journals including Nature, Science, and Nature Communications. ICMRBS Founder's Medal (2018) EMBO Young Investigator (2014) ERC starting grant (2011) SNSF professorship (2010) SNSF scholarship for young researchers (2008) Professor Hiller supervises numerous PhD students and postdoctoral researchers, with many alumni having secured prestigious positions in academia and industry. His laboratory maintains strong collaborations across multiple institutions and has received significant funding through ERC grants and other competitive mechanisms. The Hiller group also operates advanced NMR facilities that serve the broader research community at the University of Basel.

Official University Profile

David N. LangelaanView profile

Associate Professor

Dalhousie UniversityCanada

David N. Langelaan is an Associate Professor in the Department of Biochemistry and Molecular Biology at Dalhousie University, within the Faculty of Medicine. He holds a PhD from Dalhousie University and has been a department member since 2016. His research focuses on structural biology, protein-protein interactions, cellular signaling, and protein engineering. Key projects include hydrophobin characterization and engineering, studying MITF's role in melanoma and development, and analyzing rhodoquinone biosynthesis in anaerobic environments. Education: PhD, Dalhousie University. Research Themes: Structural biology, protein assemblies, microbial biochemistry, cancer biology. His lab employs techniques like NMR spectroscopy, X-ray crystallography, and isothermal titration calorimetry. Current lab members include graduate students (Raymond He, Trilok Neupane) and honours students (Alex Bouchard, Janani Venkat). Funding is provided by agencies such as NSERC, CFI, and the Dalhousie Medical Research Foundation. Publications highlight contributions to antimicrobial mechanisms, transcription factor signaling, and hydrophobin self-assembly. Recent work examines MITF coactivator interactions and rhodoquinone biosynthesis pathways in bacteria.

Official University Profile

Michael W. ShawView profile

Professor

University of ReadingUnited Kingdom

Professor Michael W. Shaw is a distinguished academic at the University of Reading's School of Agriculture, Policy and Development, Department of Plant Sciences, with a research career spanning over two decades. His expertise lies at the intersection of plant pathology, disease epidemiology, and sustainable disease management strategies. Shaw's research interests encompass plant-pathogen interactions , particularly focusing on fungal diseases affecting major crops. His work investigates the epidemiology of plant diseases , fungicide resistance mechanisms , biological control strategies , and asymptomatic pathogen infections . He has made significant contributions to understanding pathogen evolution, host specificity, and the environmental factors influencing disease development. His recent publications demonstrate a consistent research trajectory examining the molecular, ecological, and epidemiological aspects of plant diseases. Shaw's work spans multiple pathosystems including Botrytis cinerea (gray mold), Venturia inaequalis (apple scab), begomoviruses affecting okra, and banana Xanthomonas wilt. His research integrates molecular techniques, field studies, and mathematical modeling to address complex plant health challenges. Professor Shaw has contributed significantly to the understanding of fungicide resistance development, particularly in cereal pathogens, and has explored innovative approaches to disease management through biological control agents and integrated strategies. His work on asymptomatic infections has revealed novel insights into host-pathogen relationships that extend beyond traditional disease paradigms. His collaborative research network spans internationally, with co-authors from multiple countries, reflecting the global relevance of his work in plant health and food security. Shaw's research has practical applications for sustainable agriculture and crop protection strategies worldwide.

Official University Profile

Cynthia M McMillenView profile

Assistant Professor

University of PittsburghUnited States

Cynthia M McMillen is a Research Assistant Professor in the Department of Infectious Diseases and Microbiology at the University of Pittsburgh's Graduate School of Public Health, focusing on bunyavirus tropism and vertical transmission mechanisms using placental models and animal systems. Her educational background includes: Bachelor of Science in Biology from West Virginia University (2010) Ph.D. in Immunology and Microbial Pathogenesis from West Virginia University (2016) Post-doctoral training at University of Pittsburgh's Center for Vaccine Research (2019-2022) Dr. McMillen's research centers on bunyaviruses (Rift Valley fever, Cache Valley, Schmallenberg, La Crosse), investigating vertical transmission through placenta explants and rodent models. She develops 2D/3D trophoblast organoids to study host-virus interactions and creates therapeutics including neutralizing antibodies and inducible RNAi systems. Her publication record (2016-2024) demonstrates consistent focus on Rift Valley fever virus pathogenesis, vertical transmission mechanisms, and therapeutic interventions. Key contributions include establishing congenital infection models, testing antibody-based fetal protection strategies, and analyzing vaccine strain attenuation at the maternal-fetal interface. Dr. McMillen actively mentors students through classroom instruction and laboratory guidance, having served as guest lecturer for virology, immunology, and microbiology courses at University of Pittsburgh and West Virginia University since 2012. She conducts high-containment research within the Center for Vaccine Research and Regional Biocontainment Laboratory, utilizing placenta explants and trophoblast organoid systems to dissect viral tropism and transmission pathways.

Official University Profile

Francesca ChiodiView profile

Professor

Karolinska InstitutetSweden

Francesca Chiodi is a Senior Professor in the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet, Sweden. Her research focuses on HIV pathogenesis, host-microbe interactions, and immune responses in infectious diseases. She holds a Docent title from Karolinska Institutet (1991) and has been continuously employed there since 2004. Her work spans virology, immunology, and clinical trials, with emphasis on HIV prevention strategies, mucosal immunity, and translational research. Research highlights include studies on HIV pre-exposure prophylaxis (PrEP), host gene expression in foreskin tissue, and viral surface protein epitope profiling. She has led projects evaluating SARS-CoV-2 responses in mucosal tissues and contributed to global initiatives like the CHAPS study in sub-Saharan Africa. Her division, the Division of Host-Microbe , investigates microbial pathogenesis and immune mechanisms in chronic infections. Key collaborations include studies on B-cell dysfunction in HIV and TB co-infections, as well as vaccine design for immunocompromised populations. Publications (2020–2024) reflect her focus on clinical trials, transcriptomic analyses, and translational models. She has advised numerous collaborative studies but no formal student advisees are listed. Research funding includes grants for mucosal HIV prevention and SARS-CoV-2 pathogenesis studies. Ongoing work explores immune reconstitution in early antiretroviral therapy and correlates of protective immunity in mucosal tissues.

Official University Profile

Andrés J. GarcíaView profile

Professor

Georgia Institute of TechnologyUnited States

Andrés J. García is the Executive Director of the Parker H. Petit Institute for Bioengineering & Bioscience and a Regents’ Professor in the George Woodruff School of Mechanical Engineering at Georgia Institute of Technology. His research focuses on engineered biomaterials for regenerative medicine, including tissue repair, inflammation modulation, and cell adhesion mechanisms. He co-founded three startups (CellectCell, CorAmi Therapeutics, iTolerance) and holds multiple patents in biomaterials and drug delivery systems. Education: Ph.D., University of Pennsylvania, 1996 M.S.E., University of Pennsylvania, 1992 B.S., Cornell University, 1991 Research Interests: García’s work integrates engineering, materials science, and cell biology to develop biomaterials that direct cellular responses. Key areas include: Biomaterial platforms for bone repair and vascularization Immunomodulatory hydrogels for islet transplantation Antibacterial hydrogels for implant infection control Organoid generation using synthetic hydrogels Mechanisms of cell adhesion and mechanotransduction Publications: Over 30+ peer-reviewed articles in Nature Communications , Science Advances , Biomaterials , and others, highlighting innovations in hydrogel design, stem cell therapies, and biomaterial-driven tissue repair. Awards: Member of both the National Academy of Engineering and National Academy of Medicine (2021), Clemson Award for Basic Research (2012), and Fellowships with the American Society of Mechanical Engineers and AAAS. Labs/Teams: Leads the García Laboratory, collaborating across disciplines to translate biomaterials research into clinical applications. Active in startup partnerships and federal grants (e.g., NSF, NIH).

Official University Profile